These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
    Author: Murta EF, de Freitas MM, Velludo MA.
    Journal: Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021.
    Abstract:
    Twenty-five women with fibrocystic breast disease were investigated in a double-blind study using treatment with bromocriptine (5 to 7.5 mg/day for 3 months) or placebo. Estradiol and progesterone measurements did not show any changes before, during or after treatment. Serum prolactin levels were reduced during the use of bromocriptine. Histologic evaluation demonstrated a decrease of epithelial hyperplasia and arrest of the cystic dilation picture after treatment with bromocriptine.
    [Abstract] [Full Text] [Related] [New Search]